
MANÜ Telehealth Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7/10
Best for: Cash-pay shoppers wanting low daily-cost compounded GLP-1 with simple online onboarding
MANÜ Telehealth is a solid telehealth option with balanced features and pricing.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
MANÜ Telehealth is a US online platform offering compounded GLP-1 weight loss medication including injectable tirzepatide and semaglutide, with add-ons like MIC Ultraburn and NAD+ injections. It runs a 100% online process with board-certified physicians, monthly check-ins, free shipping, and no insurance required, compounding from US 503A pharmacies. The site advertises GLP-1s from about $4 to $5/day. State availability changes and is confirmed at signup. Hormone optimization is mentioned but not the primary focus. The compounded medications are not FDA-evaluated.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to MANÜ Telehealth
Sunlight
Best for: compounded GLP-1 with unlimited telehealth visits and free shipping
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
MANÜ Telehealth at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Compounded tirzepatide, Compounded semaglutide
- Starting price
- $120/mo
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored MANÜ Telehealth
Each dimension is scored algorithmically from MANÜ Telehealth’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.9/10At $120/mo, MANÜ Telehealth runs about 29% below the $170 median for GLP-1 providers.
Effectiveness25%
7.4/10MANÜ Telehealth offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
6.7/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
7.3/10Core details confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy (last checked 2026-06-06).
Accessibility10%
5.7/10MANÜ Telehealth's exact state footprint isn't published — confirm coverage in your state before signing up. Insurance pathways are offered for eligible patients.
Support10%
5.2/10MANÜ Telehealth provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this MANÜ Telehealth review
Last checked July 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with MANÜ Telehealth
We walked MANÜ Telehealth’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete an online health assessment answering medical questions.
- 2A physician reviews your information and prescribes if you qualify.
- 3Compounded GLP-1 medication (tirzepatide or semaglutide) is shipped from a licensed U.S. 503A pharmacy.
- 4Track progress with ongoing medical-team support.
- Advertises 'GLP-1s from $4/day' / '$5/day' but exact pricing appears only on product pages / in the application, not upfront.
- Subscription can be cancelled at any time by contacting support.
- Free and discreet shipping mailed directly from the pharmacy.
- Uses compounded medication from a 503A pharmacy.
MANÜ Telehealth customer support
- Phone
- +1 (786) 460-9055
GLP-1 medications MANÜ Telehealth offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Peptides MANÜ Telehealth offers
Beyond GLP-1s, MANÜ Telehealth also offers these peptides — tap any for our evidence-based guide.
Pricing
Prices re-verified
Ready to get started?
Plans and promotions change often — check MANÜ Telehealth's current pricing and active discounts before you decide.
What we like
- Compounded GLP-1s advertised from about $4-$5/day
- 100% online with free discreet shipping and no insurance needed
- Compounds exclusively from US 503A pharmacies
- Add-on options like MIC Ultraburn and NAD+
Watch-outs
- Per-dose pricing is gated behind login/signup, not public
- State availability changes and is only confirmed at signup
- Compounded medications are not FDA-evaluated
MANÜ Telehealth: a low daily-cost compounded GLP-1 shop, if you don't mind signing up to see prices
MANÜ Telehealth (yes, the brand is stylized with an umlaut) is a no-frills, cash-pay online clinic built around one promise: cheap compounded GLP-1 medication delivered to your door without insurance. It advertises tirzepatide and semaglutide from roughly four to five dollars a day, which works out to a headline of about $120 a month on the semaglutide side. That's well under the category median of $170, so on price alone MANÜ is genuinely competitive. The honest catch: the actual per-dose price list sits behind a login, so you have to start signing up before you see exactly what you'll pay.
How the pricing really works
MANÜ markets its medications on a daily-cost basis rather than a clean monthly sticker. The 'from about four to five dollars a day' framing is a starting price, and the company says the real number varies with the frequency and dose of your medication. There's no published per-dose flat table and no public same-price-at-every-dose guarantee — the pricing page is gated for people who have begun onboarding. Our $120 figure for semaglutide is the math on the four-dollar-a-day claim; treat it as a floor, not a promise, and confirm your exact dose price before you hand over a card.
- No teaser rate published: MANÜ doesn't advertise a discounted first-month promo, so the daily-cost number is roughly what you keep paying.
- No insurance, no coverage games: it's pure cash-pay, which means no prior authorizations but also no chance of a low copay if you'd otherwise qualify.
- Bundled, not à la carte: each medication package is sold as everything-in-one — consultation, medication, supplies, and shipping together.
The medications and how they reach you
MANÜ offers compounded injectable semaglutide and compounded injectable tirzepatide — the same two active ingredients behind the big-name brands, but made up by compounding pharmacies rather than the original manufacturer. The company says it sources exclusively from US 503A pharmacies, which are the kind that fill individual patient prescriptions. Everything ships free in discreet packaging straight to your home. Beyond the GLP-1s, MANÜ sells a couple of add-ons: a MIC Ultraburn injection and NAD+ shots. Hormone optimization gets a mention too, but it clearly isn't the main event here — weight-loss injections are.
What's actually in the package
MANÜ's bundling is one of its clearer selling points. The included online consultation connects you with board-certified physicians, and the plan comes with monthly medical check-ins to adjust your titration. Medication, injection supplies, and shipping are all rolled into the one price, so there shouldn't be a surprise pharmacy bill or a separate shipping charge stacked on top.
What genuinely sets MANÜ apart
The differentiator is simple and real: aggressive daily-cost pricing on compounded GLP-1s with a completely online, insurance-free funnel. If your only goal is to get tirzepatide or semaglutide as cheaply as possible and you're comfortable with compounded medication, MANÜ's four-to-five-dollar-a-day framing puts it at the low end of the market — far below the four-figure list prices the brand-name versions can carry without coverage. The flip side is that MANÜ keeps things lean: there's no labs program, no dedicated coaching, just medication plus monthly check-ins and a couple of injectable add-ons.
Who should choose it — and who should skip it
MANÜ fits the budget-driven, self-directed patient: someone who already knows they want a compounded GLP-1, wants the lowest realistic monthly cost, and doesn't need hand-holding. It's a poor fit if you want price transparency before committing, since you can't see the real per-dose numbers without entering the funnel. It's also wrong for anyone who specifically wants brand-name Wegovy, Ozempic, Mounjaro, or Zepbound — MANÜ deals in compounded medication only — and for anyone who'd rather use insurance or wants a structured coaching, nutrition, or lab component.
- Good fit: cash-pay shoppers chasing the lowest daily cost on compounded semaglutide or tirzepatide with simple online onboarding.
- Skip it if: you need to see exact pricing up front, want brand-name medication, plan to bill insurance, or want labs and coaching baked in.
Trust, safety, and the compounding caveat
The most important thing to understand about MANÜ — and every compounding-based provider — is that compounded medications are not FDA-evaluated for safety, effectiveness, or quality the way brand-name drugs are. MANÜ displays the appropriate compounding disclaimer, and on the positive side it says it works only with US 503A pharmacies and uses board-certified physicians with monthly check-ins. We found no FDA warning letters on file for MANÜ. Two transparency knocks keep our confidence in check, though: the per-dose pricing is hidden behind login, and the list of states MANÜ serves changes and is only confirmed at signup, so you won't know for certain it operates where you live until you start the process. You can see how we weigh these factors in our scoring methodology.
Bottom line
MANÜ Telehealth is a credible budget pick for compounded GLP-1 medication: low daily cost, free discreet shipping, no insurance hassle, and a tidy all-in-one package with board-certified oversight. The trade-offs are real and worth naming — you have to enter the funnel to see true prices, state coverage is confirmed only at signup, and the medication is compounded rather than FDA-evaluated. If price is your priority and compounded therapy is acceptable to you, MANÜ earns a look. If you want transparency before you commit or brand-name product, look elsewhere.
If you're weighing alternatives, Oak ($119/month) and bmiMD ($99/month) are among the closest options we track to MANÜ Telehealth.
The Bottom Line
MANÜ Telehealth is a solid telehealth option with balanced features and pricing.
Ready to start with MANÜ Telehealth?
Starting at $120/month. See current pricing and start your free consultation.
MANÜ Telehealth might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Sesame Care (from $59/mo).
- If you want built-in coaching and behavior-change support, consider Found.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this MANÜ Telehealth review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See MANÜ Telehealth's current pricing
Plans start at $120/month. Start your free consultation to check eligibility and today's price.